PDCD1 and small cell lung carcinoma: In small cell cancer of the lung, two phase 3 trials have shown an improvement in OS with the addition of Programmed cell death protein 1 (PD-1)/Programmed Cell Death Ligand 1 (PD-L1) directed therapy in combination with first-line chemotherapy [55,56].